117.00
-8.00
(-6.40%)
As of 9:42:25 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 6 |
| Avg. Estimate | 3.16B | 3.25B | 13.04B | 13.99B |
| Low Estimate | 3.08B | 3.13B | 12.69B | 13.64B |
| High Estimate | 3.2B | 3.29B | 13.26B | 14.41B |
| Year Ago Sales | 3.1B | 3.18B | 12.64B | 13.04B |
| Sales Growth (year/est) | 2.02% | 2.02% | 3.17% | 7.31% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RYD.F | -- | -- | -- | -- |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 2/13/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 12/12/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 10/25/2024 |
| Maintains | Baird: Outperform to Outperform | 7/26/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 7/9/2024 |
| Initiated | Stephens & Co.: Equal-Weight | 7/8/2024 |